UPB

Upstream Bio Stock Analysis

AI Rating

Low
  • Quality3/10
  • Growth↓ 4/10
  • Value↓ 0/10
Upstream Bio sales and earnings growth
UPB Growth
Neutral
  • Revenue Y/Y↑ 20.42%
  • EPS Y/Y↑ 52.33%
  • FCF Y/Y↓ -123.58%
Upstream Bio gross and profit margin trends
UPB Profitability
Fair
  • Gross margin ↑ 100.00%
  • EPS margin↓ -5026.00%
  • ROIC 5Y↓ 0.00%
Upstream Bio net debt vs free cash flow
UPB Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Upstream Bio stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks